Migraines move through four distinct phases, experts say. Here's when to expect relief.

TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and ...

A common migraine drug has been linked to an alarming health risk.

CGRP therapies have transformed migraine care, but has the focus on this pathway overshadowed other targets? With many patients still lacking relief, researchers are exploring alternatives.

The Coalition for Headache and Migraine Patient (CHAMP) is a nonprofit organization that aims to support people with headache ...

The studies enrolled around 1800 participants to test the drug's safety and efficacy in preventing both chronic and episodic migraine.

A new Frontiers in Medicine review argues that gut microbial metabolites, from short-chain fatty acids to nitrate-reducing ...

Ensuring that emergency department personnel had easy access to the American Headache Society guidelines for managing ...

New estimates suggest almost four million Australians live with migraine, with nearly two-thirds potentially undiagnosed.

Recognizing pre-migraine symptoms, which can include mood changes, muscle pain, and fatigue, is crucial for potentially preventing a full migraine attack. Taking action at the first sign of ...

Uncover the latest and most impactful research in Vestibular Migraine Diagnosis and Management. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field.

A multimodal MRI study of 123 people finds that migraine patients show reduced perivascular diffusion markers and, in chronic ...